Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nicolas Magné is active.

Publication


Featured researches published by Nicolas Magné.


Cancer Letters | 2012

Targeting a cornerstone of radiation resistance: cancer stem cell.

Coralie Moncharmont; Antonin Levy; Marion Gilormini; Gérald Bertrand; Cyrus Chargari; Gersende Alphonse; Dominique Ardail; Claire Rodriguez-Lafrasse; Nicolas Magné

In radiation oncology, cancer stem cells (CSCs) have become an important research field. In fact, it appears that most cancer types contain populations of cells that exhibit stem-cell properties. CSCs have the ability to renew indefinitely, which can drive tumor development and metastatic invasion. As those cells are classically resistant to conventional chemotherapy and to radiation therapy, they may contribute to treatment failure and relapse. Over past decades, preclinical research has highlighted that variations in the CSCs content within tumor could affect their radiocurability by interfering with mechanisms of DNA repair, redistribution in the cell cycle, tumor cells repopulation, and hypoxia. It is now possible to isolate particular cells expressing specific surface markers and thus better investigating CSCs pathways. Numerous inhibitory agents targeting these specific signaling pathways, such as Notch and Wnt/B-catenin, are currently evaluated in early clinical trials. By targeting CSCs, tumor radioresistance could be potentially overcome to improve outcome for patients with solid malignancies. Radiation therapy using ion particles (proton and carbon) may be also more effective than classic photon on CSCs. This review presents the major pathophysiological mechanisms involved in CSCs radioresistance and recent developments for targeted strategies.


Stem Cell Reviews and Reports | 2014

Targeting head and neck cancer stem cells to overcome resistance to photon and carbon ion radiation.

Gérald Bertrand; Mira Maalouf; Antony Boivin; Priscillia Battiston-Montagne; Michael Beuve; Antonin Levy; Patrice Jalade; Claudia Fournier; Dominique Ardail; Nicolas Magné; Gersende Alphonse; Claire Rodriguez-Lafrasse

Although promising new radiation therapy techniques such as hadrontherapy are currently being evaluated in the treatment of head and neck malignancies, local control of head and neck squamous cell carcinoma (HNSCC) remains low. Here, we investigated the involvement of cancer stem-like cells (CSCs) in a radioresistant HNSCC cell line (SQ20B). Stem-like cells SQ20B/SidePopulation(SP)/CD44+/ALDHhigh were more resistant to both photon and carbon ion irradiation compared with non-CSCs. This was confirmed by a BrdU labeling experiment, which suggests that CSCs were able to proliferate and to induce tumorigenicity after irradiation. SQ20B/SP/CD44+/ALDHhigh were capable of an extended G2/M arrest phase in response to photon or carbon ion irradiation compared with non-CSCs. Moreover, our data strongly suggest that resistance of CSCs may result from an imbalance between exacerbated self-renewal and proliferative capacities and the decrease in apoptotic cell death triggering. In order to modulate these processes, two targeted pharmacological strategies were tested. Firstly, UCN-01, a checkpoint kinase (Chk1) inhibitor, induced the relapse of G2/M arrest and radiosensitization of SQ20B-CSCs. Secondly, all-trans retinoic acid (ATRA) resulted in an inhibition of ALDH activity, and induction of the differentiation and radiosensitization of SQ20B/SP/CD44+/ALDHhigh cells. The combination of ATRA and UCN-01 treatments with irradiation drastically decreased the surviving fraction at 2Gy of SQ20B-CSCs from 0.85 to 0.38 after photon irradiation, and from 0.45 to 0.21 in response to carbon ions. Taken together, our results suggest that the combination of UCN-01 and ATRA represent a promising pharmacological-targeted strategy that significantly sensitizes CSCs to photon or carbon ion radiation.


Nanomedicine: Nanotechnology, Biology and Medicine | 2015

Combining ultrasmall gadolinium-based nanoparticles with photon irradiation overcomes radioresistance of head and neck squamous cell carcinoma

Imen Miladi; Marie-Thérèse Aloy; Emma Armandy; Pierre Mowat; David Kryza; Nicolas Magné; Olivier Tillement; François Lux; Claire Billotey; Marc Janier; Claire Rodriguez-Lafrasse

Gadolinium based nanoparticles (GBNs, diameter 2.9±0.2nm), have promising biodistribution properties for theranostic use in-vivo. We aimed at demonstrating the radiosensitizing effect of these GBNs in experimental radioresistant human head and neck squamous cell carcinoma (SQ20B, FaDu and Cal33 cell lines). Combining 0.6mM GBNs with 250kV photon irradiation significantly decreased SQ20B cell survival, associated with an increase in non-reparable DNA double-strand breaks, the shortening of G2/M phase blockage, and the inhibition of cell proliferation, each contributing to the commitment of late apoptosis. Similarly, radiation resistance was overcome for SQ20B stem-like cells, as well as for FaDu and Cal33 cell lines. Using a SQ20B tumor-bearing mouse model, combination of GBNs with 10Gy irradiation significantly delayed tumor growth with an increase in late apoptosis and a decrease in cell proliferation. These results suggest that GBNs could be envisioned as adjuvant to radiotherapy for HNSCC tumors.


Journal of Cell Death | 2017

In Vitro Cell Death Determination for Drug Discovery: A Landscape Review of Real Issues

Benoîte Méry; Jean-Baptiste Guy; Alexis Vallard; Sophie Espenel; Dominique Ardail; Claire Rodriguez-Lafrasse; Chloé Rancoule; Nicolas Magné

Cell death plays a crucial role for a myriad of physiological processes, and several human diseases such as cancer are characterized by its deregulation. There are many methods available for both quantifying and qualifying the accurate process of cell death which occurs. Choosing the right assay tool is essential to generate meaningful data, provide sufficient information for clinical applications, and understand cell death processes. In vitro cell death assays are important steps in the search for new therapies against cancer as the ultimate goal remains the elaboration of drugs that interfere with specific cell death mechanisms. However, choosing a cell viability or cytotoxicity assay among the many available options is a daunting task. Indeed, cell death can be approached by several viewpoints and require a more holistic approach. This review provides an overview of cell death assays usually used in vitro for assessing cell death so as to elaborate new potential chemotherapeutics and discusses considerations for using each assay.


Bulletin Du Cancer | 2015

Nanoparticules et radiothérapie

V. Calugaru; Nicolas Magné; J. Hérault; Sylvie Bonvalot; Christophe Le Tourneau; Juliette Thariat

BACKGROUNDnNanoparticles have emerged in oncology as new therapeutic agents of distinct biochemical and physical properties, and pharmacokinetics. Current rationale and clinical applications in combination with radiation therapy were analyzed.nnnMATERIAL AND METHODSnA review of the literature was conducted on nanoparticles as radiosensitizers, with a focus on metallic nanoparticles and radiosensitization mechanisms.nnnRESULTSnNanoparticles are mainly used as vectors for drugs or to potentiate dose deposit selectively in irradiated tissues. Preclinical data suggest a predominating effect in the kilovoltage range through a photoelectric effect and a potential in the megavoltage range under a combination of physical and biochemical (diameter, concentration, site of infusion etc) conditions. Several clinical trials are ongoing with metallic/crystalline nanoparticles.nnnCONCLUSIONnNanoparticles have shown a potential for better therapeutic index with radiation therapy, which is being increasingly investigated clinically.


Cancer Letters | 2015

Cellular and molecular portrait of eleven human glioblastoma cell lines under photon and carbon ion irradiation

S. Ferrandon; Nicolas Magné; P. Battiston-Montagne; N.-H. Hau-Desbat; O. Diaz; Michael Beuve; J. Constanzo; C. Chargari; D. Poncet; E. Chautard; Dominique Ardail; Gersende Alphonse; Claire Rodriguez-Lafrasse

This study aimed to examine the cellular and molecular long-term responses of glioblastomas to radiotherapy and hadrontherapy in order to better understand the biological effects of carbon beams in cancer treatment. Eleven human glioblastoma cell lines, displaying gradual radiosensitivity, were irradiated with photons or carbon ions. Independently of p53 or O(6)-methylguanine-DNA methyltransferase(1) status, all cell lines responded to irradiation by a G2/M phase arrest followed by the appearance of mitotic catastrophe, which was concluded by a ceramide-dependent-apoptotic cell death. Statistical analysis demonstrated that: (i) the SF2(2) and the D10(3) values for photon are correlated with that obtained in response to carbon ions; (ii) regardless of the p53, MGMT status, and radiosensitivity, the release of ceramide is associated with the induction of late apoptosis; and (iii) the appearance of polyploid cells after photon irradiation could predict the Relative Biological Efficiency(4) to carbon ions. This large collection of data should increase our knowledge in glioblastoma radiobiology in order to better understand, and to later individualize, appropriate radiotherapy treatment for patients who are good candidates.


Cell Stress & Chaperones | 2013

Impact of hyperthermic intraperitoneal chemotherapy on Hsp27 protein expression in serum of patients with peritoneal carcinomatosis

Vahan Kepenekian; Marie Thérèse Aloy; Nicolas Magné; Guillaume Passot; Emma Armandy; Evelyne Decullier; Annie Sayag-Beaujard; François Noël Gilly; Olivier Glehen; Claire Rodriguez-Lafrasse

Despite the strong rationale for combining cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal carcinomatosis, thermotolerance and chemoresistance might result from heat shock protein overexpression. The aim of the present study was thus to determine whether the heat shock protein 27 (Hsp27), a potential factor in resistance to treatment, could have a higher level in serum from patients under this combined therapy. Patients receiving CRS plus HIPEC for peritoneal carcinomatosis (group 1), patients with cancer or a history of cancer undergoing abdominal surgery (group 2), and patients without malignancies undergoing abdominal surgery (group 3) were included. Hsp27 serum levels were determined before and at different times following CRS and HIPEC using enzyme-linked immunosorbent assay. In group 1 (nu2009=u200925), the high Hsp27 levels, observed at the end of surgery compared with before (pu2009<u20090.0001), decreased during HIPEC, but remained significantly higher than before surgery (pu2009<u20090.0005). In groups 2 (nu2009=u200911) and 3 (nu2009=u200915), surgery did not significantly increase Hsp27 levels. A targeted molecular strategy, inhibiting Hsp27 expression in tumor tissue, could significantly reduce resistance to the combined CRS plus HIPEC treatment. This approach should be further assessed in a clinical phase I trial.


Scientific Reports | 2017

Dual “mAb” HER family blockade in head and neck cancer human cell lines combined with photon therapy

Jean-Baptiste Guy; Benoîte Méry; Edouard Ollier; Sophie Espenel; Alexis Vallard; Anne-Sophie Wozny; Stéphanie Simonet; Alexandra Lauret; Priscillia Battiston-Montagne; Dominique Ardail; Gersende Alphonse; Chloé Rancoule; Claire Rodriguez-Lafrasse; Nicolas Magné

Head and neck cancer stem cells (CSCs) are highly resistant to treatment. When EGFR is overexpressed in head and neck squamous cell carcinoma (HNSCC), HER2 and HER3 are also expressed. The aim of the present study was to investigate the effect of HER1/2/3 blockade through a combination of cetuximab and pertuzumab, with or without photon irradiation, on the proliferation and migration/invasion capabilities of an HNSCC chemo- and radioresistant human cell line (SQ20B) and its corresponding stem cell subpopulation. Cell proliferation, migration and invasion were studied after treatment with cetuximab +/− pertuzumab +/− 10u2009Gy photon irradiation. EGFR, phospho-EGFR, HER2 and HER3 protein expression levels were studied. Activation or inhibition of the RAS/MAPK and AKT-mTOR downstream signalling cascades was investigated through phospho-AKT and phospho-MEK1/2 expression. Cetuximab strongly inhibited SQ20B and FaDu cell proliferation, migration and invasion, whereas it had little effect on SQ20B-CSCs. Cetuximab–pertuzumab combined with radiation significantly inhibited SQ20B and FaDu cell and SQ20B-CSC proliferation, migration and invasion. Cetuximab–pertuzumab with 10u2009Gy photon irradiation switched off both phospho-AKT and phospho-MEK1/2 expression in the three populations. The triple therapy is therefore thought to inhibit SQ20B cells, SQ20B-CSCs and FaDu cells through an AKT-mTOR and Ras-MAPK downstream signalling blockade.


Forum de la Recherche en Cancérologie Auvergne-Rhône-Alpes 2017 | 2017

Ciblage des cellules souches cancéreuses dans les cancers ORL : effet synergique de l’ABT-199 et du cetuximab en association à la radiothérapie photonique

Jean-Baptiste Guy; Sophie Espenel; Anne-Sophie Wozny; Priscillia Battiston-Montagne; Chloé Rancoule; Gersende Alphonse; Dominique Ardail; Claire Rodriguez-Lafrasse; Nicolas Magné


15th International Congress of Radiation Research - ICCR 2015 | 2015

Cancer Stem Cells and EMT: Guilty of HNSCC Recurrences but Condemned by the Combination of Carbon Ion Irradiation and EGFR inhibition

Claire Rodriguez-Lafrasse; Coralie Moncharmont; Priscillia Battiston-Montagne; Ghassan Hamdan; Anne Wozny; Jean-Baptiste Guy; Michael Beuve; Gersende Alphonse; Nicolas Magné

Collaboration


Dive into the Nicolas Magné's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Claire Rodriguez-Lafrasse

Claude Bernard University Lyon 1

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michael Beuve

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Antonin Levy

Université Paris-Saclay

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge